Effects of Physical Exercise on Endothelial Function and DNA Methylation by L. Ferrari et al.
International  Journal  of
Environmental Research
and Public Health
Article
Effects of Physical Exercise on Endothelial Function
and DNA Methylation
Luca Ferrari 1,† , Marco Vicenzi 1,2,†, Letizia Tarantini 1, Francesco Barretta 1,3, Silvia Sironi 1,
Andrea A. Baccarelli 4, Marco Guazzi 5 and Valentina Bollati 1,*
1 EPIGET, Epidemiology, Epigenetics and Toxicology Lab, Department of Clinical Sciences and Community
Health, University of Milan, via san Barnaba 8, 20122 Milan, Italy
2 Department of Cardiology, Fondazione IRCSS Ca’ Granda, Ospedale Maggiore Policlinico, Department of
Clinical Sciences and Community Health, University of Milan, via san Barnaba 8, I-20122 Milan, Italy
3 Unit of Clinical Epidemiology and Trial Organization, Fondazione IRCCS Istituto Nazionale dei Tumori,
I-20133 Milan, Italy
4 Department of Environmental Health Sciences, Columbia University Mailman School of Public Health,
New York, NY 10032, USA
5 Cardiology University Department, Heart Failure Unit, University of Milan, IRCCS Policlinico San Donato,
San Donato Milanese, I-20097 Milan, Italy
* Correspondence: valentina.bollati@unimi.it; Tel.: +39-02-5032-0127
† These authors contributed equally to the manuscript.
Received: 14 June 2019; Accepted: 14 July 2019; Published: 16 July 2019


Abstract: Essential hypertension is the leading preventable cause of death in the world.
Epidemiological studies have shown that physical training can reduce blood pressure (BP), both in
hypertensive and healthy individuals. Increasing evidence is emerging that DNA methylation
is involved in alteration of the phenotype and of vascular function in response to environmental
stimuli. We evaluated repetitive element and gene-specific DNA methylation in peripheral blood
leukocytes of 68 volunteers, taken before (T0) and after (T1) a three-month intervention protocol
of continuative aerobic physical exercise. DNA methylation was assessed by bisulfite-PCR and
pyrosequencing. Comparing T0 and T1 measurements, we found an increase in oxygen consumption
at peak of exercise (VO2peak) and a decrease in diastolic BP at rest. Exercise increased the levels of
ALU and Long Interspersed Nuclear Element 1 (LINE-1) repetitive elements methylation, and of
Endothelin-1 (EDN1), Inducible Nitric Oxide Synthase (NOS2), and Tumour Necrosis Factor Alpha
(TNF) gene-specific methylation. VO2peak was positively associated with methylation of ALU,
EDN1, NOS2, and TNF; systolic BP at rest was inversely associated with LINE-1, EDN1, and NOS2
methylation; diastolic BP was inversely associated with EDN1 and NOS2 methylation. Our findings
suggest a possible role of DNA methylation for lowering systemic BP induced by the continuative
aerobic physical training program.
Keywords: physical exercise; hypertension; DNA methylation; pyrosequencing;
cardiovascular disease
1. Introduction
Essential hypertension (EH) is a major public health concern and the leading preventable cause of
premature death in many countries, due to its high prevalence and its association with coronary heart
disease, stroke, renal disease, and other chronic disorders [1–3].
The association between EH and cardiovascular disease is supported by several studies [4–6].
Patients with blood pressure ≥ 180/110 mmHg have a greater risk of developing coronary heart disease
than those with blood pressures ≤ 120/80 mmHg [7,8].
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It has been estimated that by 2025 1.5 billion people will be affected by EH [9], resulting in a
tremendous impact in terms of public health. Therefore, the World Health Organization (WHO)
recommended a 25% relative reduction of the prevalence of hypertension among the public health
targets to be achieved within 2020 in order to reduce the global burden of diseases [10].
EH is regarded as a multifactorial condition, the aetiology and severity of which are influenced
by dynamic interactions among genetic and environmental factors [11,12]. It has been demonstrated
that lifestyle modifications, including increased physical activity, can significantly contribute to blood
pressure control [13,14]. A sedentary lifestyle increases the risk of many adverse health conditions,
including cardiovascular diseases, and shortens life expectancy [15–17], whereas increased occupational
or leisure-time physical activity is associated with lower levels of blood pressure [18–20]. A number of
intervention studies have been conducted so far, supporting the role of physical activity in modulating
blood pressure [21–23].
Physical training reduces blood pressure improving endothelial function pressure in hypertensive
patients as well as in healthy individuals [24–26]. The mechanism of improvement in endothelial
function during exercise has not been fully clarified, but it is thought that regular aerobic exercise
reduces cellular reactive oxygen species (ROS) and increases nitric oxide (NO) bioavailability [27].
Environmental exposure and lifestyle factors impact on the genome by inducing epigenetic
modifications and therefore making epigenetic determinants important susceptibility factors involved
in complex multifactorial diseases, such as EH [28,29]. Interestingly, it was reported that conditions
influenced by epigenetics, such as EH, can be reversed simply by making different lifestyle choices [30,
31]. In addition, we reported, in a prospective study of aging conducted in the Boston area, that levels
of leukocyte long interspersed nuclear element 1 (LINE-1) methylation predict future risks of ischemic
heart disease and stroke [32].
The aim of the present study was to evaluate the effects of a three-month controlled aerobic physical
training on DNA methylation, in hypertensive and healthy subjects. In particular, we measured DNA
methylation in repetitive elements (ALU and LINE-1 sequences) as well as in specific genes chosen for
the important role they have in inflammation and hypertension development processes: endothelial
nitric oxide synthase (NOS3), endothelin 1 (EDN1), intercellular adhesion molecule 1 (ICAM1),
inducible nitric oxide synthase (NOS2), toll-like receptor 2 (TLR2) and tumour necrosis factor alpha
(TNF). Our research could provide important biological bases, as well as informative molecular markers,
for assisting in a critical interpretation of clinical studies that suggest aerobic physical activity is
potentially able to reduce risk and incidence of cardiovascular events in the general population.
2. Materials and Methods
2.1. Patients and Study Design
Subjects participating in this study were recruited from the Hypertension Outpatients Clinic at San
Paolo Hospital, Milano, Italy. Forty-four patients with Essential Hypertension were enrolled at the time
0 (T0) among adults, immediately after the diagnosis or in the contest of a sub-optimal pharmacological
treatment, and agreed to participate to an aerobic exercise training. Twenty-four normotensive healthy
subjects had also been enrolled and were asked to follow the same exercise-training protocol of patients.
The eligibility criteria for participants were: (1) being older than 18 years at enrolment; (2) being
younger than 70 years at enrolment; (3) agreement to sign an informed consent and donate a blood
sample. Exclusion criteria included: previous diagnosis of cancer, heart disease or stroke in the last
year or other chronic diseases such as multiple sclerosis, Alzheimer’s disease, Parkinson’s disease,
depression, bipolar disorder, schizophrenia, and epilepsy. Each study subject was asked to sign a
consent form explaining the study aims and procedures and Institutional board approval was obtained
(109/2012, Ethical Committee of Azienda Ospedaliera San Paolo, Milan).
The procedure for the first visit at baseline included: clinical examination, measurements of height,
weight, systolic and diastolic blood pressure (respectively, SBP and DBP), information on the objectives
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and modalities of the study, signing of informed consent form, drawing of 13 mL of blood, to determine
fasting blood glucose, lipid profile, liver function, creatine phosphokinase (CPK), renal function,
electrolytes, complete blood count (CBC), and to extract DNA. A cardiopulmonary exercise testing
(CPET) was performed in order to determine the functional capacity of each subject, to assess the
oxygen consumption at peak of exercise (VO2peak, expressed in mL/kg/min and in % compared to
a predicted maximum). Systemic blood pressure measurements were performed every 2 min and
12-lead continuous electrocardiogram (EKG) monitoring was recorded for the entire duration of CPET.
All subjects were invited to limit lifestyle changes (diet, alcohol, smoke habit, hours of nightly sleep)
during the 3-month training period except for the assigned physical activity program.
2.2. Exercise-Training Program
After the T0 visit, the study subjects started an aerobic exercise-training program four times per
week, for a continuous 12 weeks. The protocol requested to perform at least 4 physical activity training
sessions of 40 min a week (exercise on a stationary bike or jogging), in order to reach and maintain
for at least 30 min the heart rate corresponding to the anaerobic threshold (AT), determined at the
enrolment (T0). We considered uncompliant those subjects performing exercise training less than
4 times per week.
After 12 weeks (T1), a first follow-up visit was conducted. Evaluation of clinical parameters and
biological sample collection was repeated, as in T0.
At the baseline and at the end of the exercise-training period, each subject underwent a
symptom-limited CPET on a cycle ergometer. VO2peak, systolic and diastolic blood pressure were
considered in the statistical analysis.
2.3. Sample Collection and DNA Methylation Analysis
We used ethylendiaminetetracetic acid (EDTA) tubes to collect 7 mL whole blood that was
immediately frozen at −80 ◦C. DNA was extracted from whole blood using the Wizard Genomic DNA
purification kit (Promega, Madison, WI, USA) following the manufacturer’s instructions.
We performed DNA methylation analyses on bisulphite-treated DNA using highly quantitative
analysis based on PCR pyrosequencing; 500 ng DNA (concentration 25 ng/µL) was treated using the
EZ DNA Methylation-Gold Kit (Zymo Research, Orange, CA, USA) according to the manufacturer’s
protocol. Final elution was performed with 200 µL M-Elution Buffer.
To estimate repetitive element methylation, we performed DNA methylation analyses of ALU
and LINE-1 repeated sequences, which allow for the amplification of a representative pool of repetitive
elements, as previously described [33] Measures of ALU and LINE-1 methylation have been shown
to be highly correlated with 5-methylcytosine content measured through high-performance liquid
chromatography and are commonly used as a surrogate of global methylation [34,35].
Primers and PCR conditions for ALU, LINE-1, NOS2, NOS3, ICAM1, TLR2, EDN1, and TNF
assays are shown in Supplementary Table S1. For each sequence, a 50 µL PCR was carried out in
25 µL GoTaq Green Master mix (Promega Corporation, Madison, WI, USA), 10 pmol forward primer,
10 pmol reverse primer, 50 ng bisulfite-treated genomic DNA, and water. PCR products were purified
and sequenced by pyrosequencing as previously described [33] using 0.3 µM sequencing primer.
2.4. Statistical Analysis
Measurements were expressed as the mean + SD. Differences between variables at rest and
after the peak exercise were tested for significance using two-sided Student’s t-test for paired data.
Unadjusted and multivariable regression models (Adjusted for gender, age, BMI and smoking status
as current/non-current) were applied to estimate the effects of a 1% increase in DNA methylation
on cardiovascular outcomes (Peak VO2/Kg, Diastolic Blood Pressure—DBP- and Systolic Blood
Pressure—SBP- at rest). All data management and statistical analyses were performed with SAS
software, version 9.4 (SAS Institute Inc; Cary, NC, USA).
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3. Results
3.1. Characteristics of the Study Participants
As summarized in Table 1, among the 68 study participants, 50 (73.5%) were males and 18 (26.5%)
were females. The mean age was 49.5 years (range: 22–70 years). Considering the Body Mass Index
(BMI) 26 (38.8%) subjects were classified as normal (BMI < 25), 32 (47.8%) subjects as overweight
(BMI > 25 and < 30) and 9 (13.4%) subjects as obese (BMI ≥ 30).
Table 1. Characteristics of the Study Participants at the Baseline (T0).
All Subjects
Diastolic Blood Pressure ≤
80 and Systolic Blood
Pressure ≤ 120
80< Diastolic Blood Pressure
≤ 90 and 120 < Systolic Blood
Pressure ≤ 140
Diastolic Blood Pressure >
90 and/or Systolic Blood
Pressure > 140
(n = 68) (n = 24, 35.3%) (n = 14, 20.6%) (n = 30, 44.1%)
Gender, n (%)
Male 50 (73.5) 17 (25.0) 9 (13.2) 24 (35.3)
Female 18 (26.5) 7 (10.3) 5 (7.4) 6 (8.8)
Age (Years), n (%)
22–40 17 (25.0) 4 (5.9) 4 (5.9) 9 (13.2)
41–60 33 (48.5) 12 (17.6) 4 (5.9) 17 (25.0)
61–70 18 (26.5) 8 (11.8) 5 (7.35) 5 (7.35)
BMI (kg/m2), n (%)
≤25 26 (38.8) 13 (19.4) 5 (7.5) 8 (11.9)
>25 and ≤30 32 (47.8) 10 (14.9) 5 (7.5) 17 (25.4)
>30 9 (13.4) 1 (1.5) 3 (4.5) 5 (7.4)
Smoking, n (%)
Never smoker 59 (86.8) 22 (32.3) 11 (16.2) 26 (38.3)
Current smoker 9 (13.2) 2 (2.9) 3 (4.4) 4 (5.9)
Compliance (Physical Training) a, n (%)
Yes 52 (76.5) 19 (27.9) 10 (14.7) 23 (33.8)
No 16 (23.5) 5 (7.3) 4 (5.9) 7 (10.3)
a Compliance was based on the completion at least four complete physical activity training sessions of 40 min a
week (exercise on a stationary bike or jogging), in order to reach and maintain for at least 30 min the heart rate
corresponding to the anaerobic threshold (AT), determined at the enrolment (T0). BMI: body mass index.
Nine participants (13.2%) were current smokers and reported a median number of 15 cigarettes
smoked every day (range between 0 and 30). For Blood Pressure, the participants showed wide
ranges of values: 24 (35.3%) were classified as normal (diastolic blood pressure ≤ 80 and systolic blood
pressure ≤ 120), 14 (20.6%) showed a border-line to mild hypertension (80 mmHg < diastolic blood
pressure ≤ 90 mmHg and 120 mmHg < systolic blood pressure ≤ 140 mmHg) and 30 (44.1%) showed
moderate hypertension (diastolic blood pressure > 90 and/or systolic blood pressure > 140).
3.2. Exercise-Induced Clinical Parameter Changes
Comparing at baseline and after 3 months of physical aerobic training protocol the clinical
parameters we considered were changed (Table 2).
Table 2. Cardiovascular outcomes at Baseline (T0) and after Physical Training (T1).
Methylation Marker Baseline (T0) Post Physical Training (T1) p-Value
Mean SD 25pct Median 75pct Mean SD 25pct Median 75pct
Peak VO2/Kg (mL min-1 Kg-1) 24.8 8.4 18.9 22.9 30.7 27.7 8.5 22.0 25.9 32.4 <0.0001
SBP at rest (mmHg) 128.9 13.8 120.0 130.0 135.0 125.0 12.4 117.5 120.0 132.5 0.0026
DBP at rest (mmHg) 85.1 12.0 80.0 82.5 90.0 81.1 10.0 75.0 80.0 85.0 0.0001
a Paired t-test. SBP: systolic blood pressure; DBP: diastolic blood pressure.
In particular, we observed an increase in VO2peak from T0 to T1 (meanT0 = 24.8 mL/min/kg,
SD = 10.0; meanT1 = 27.7 mL/min/kg, SD = 10.2; p < 0.0001) and a decrease in SBP at rest
(meanT0 = 128.9 mmHg, meanT1 = 125 mmHg; p = 0.0026) and DBP at rest (meanT0 = 85.1 mmHg;
meanT1 = 81.1 mmHg; p = 0.0001).
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3.3. Exercise-Induced DNA Methylation Changes
In parallel with the changes observed in clinical outcomes, the comparison between T0 and T1
showed the methylation in two of the six genes and in both repetitive elements as significantly changed
(Table 3).
Table 3. Methylation Level at Baseline (T0) and after Physical Training (T1).
Methylation
Marker
n Baseline (T0) Post Physical Training (T1) p-Value a
Mean SD 25pct Median 75pct Mean SD 25pct Median 75pct
ALU 67 27.5 4.4 24.4 25.6 34.1 28.9 4.6 25.2 26.5 34.5 0.007
LINE-1 59 78.2 3.0 77.0 78.5 80.5 79.8 2.2 78.7 79.9 81.2 0.001
NOS3 61 81.1 9.0 78.4 84.1 86.2 82.8 8.2 82.5 84.8 86.5 0.277
EDN1 65 1.6 0.5 1.3 1.7 1.9 2.0 1.0 1.4 1.9 2.2 0.005
NOS2 65 67.5 7.9 61.5 68.2 74.5 71.8 5.8 66.9 72.5 76.6 0.001
ICAM1 64 6.7 2.3 4.9 6.0 8.2 7.2 3.1 5.3 6.4 8.1 0.321
TLR2 66 9.6 7.2 2.8 8.9 14.0 10.3 10.8 2.5 7.5 14.2 0.686
TNF 66 14.6 6.7 11.1 13.8 16.9 14.9 5.4 12.1 14.1 16.2 0.846
a Paired t-test.
Repetitive element methylation was increased in T1 compared to T0. In particular,
ALU methylation showed a significant increase after training compared to baseline (meanT0 = 28.9%,
SD = 4.6; meanT1 = 27.5%, SD = 4.4; p = 0.007), such as LINE-1 methylation (meanT0 = 78.2%, SD = 3.0;
meanT1 = 79.8%, SD = 2.2; p = 0.001).
As we focused on gene-specific methylation, EDN1 and NOS2 showed higher methylation at the
baseline (respectively, mean = 1.6, SD = 0.5; mean = 67.5, SD = 7.9) than after training (respectively,
mean = 2.0, SD = 1.0; mean = 71.8, SD = 5.8) (p = 0.005 and p = 0.001). NOS3, ICAM1, TLR2 and TNF
showed a moderate non-significant increase in methylation (p > 0.1).
3.4. Association between Blood Pressure and Methylation Markers
Considering all the participants, methylation markers showed several significant associations
with the VO2peak, as well as with SBP and DBP (Table 4).
In particular, when we considered a multivariate model adjusted for gender, age, body mass index,
and smoking status, VO2peak was significantly associated to ALU methylation (β = 0.38, p = 0.004),
EDN1 methylation (β = 0.93, p = 0.046), NOS2 methylation (β = 0.16, p = 0.009) and TNF (β = 0.14,
p = 0.042).
SBP at rest was inversely associated with methylation of LINE-1 (β = −0.90, p = 0.023),
EDN1 (β = −3.0, p = 0.003), and NOS2 (β = −0.40, p = 0.004) and DBP at rest was inversely associated
with methylation of EDN1 (β = −1.7, p = 0.035), and NOS2 (β = −0.3, p = 0.008).
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Table 4. Unadjusted and multivariable regression models (Adjusted for gender, age, BMI and smoking
status) estimating the effects of a 1% increase in DNA methylation on cardiovascular outcomes (Peak
VO2/Kg, PAS at rest and PAD at rest).
N
Unadjusted Models Multivariable Models
β a (95% CI) p-Value β a (95% CI) p-Value
Peak VO2/Kg (mL min−1 Kg−1)
ALU 134 0.3 (0.01, 0.6) 0.045 0.38 (0.13, 0.64) 0.004
LINE-1 118 0.37 (0.02, 0.72) 0.039 0.31 (−0.01, 0.63) 0.059
NOS3 122 0.08 (−0.07, 0.24) 0.299 0.04 (−0.1, 0.18) 0.553
EDN1 130 0.95 (−0.06, 1.96) 0.064 0.93 (0.02, 1.83) 0.046
NOS2 130 0.17 (0.03, 0.3) 0.014 0.16 (0.04, 0.27) 0.009
ICAM1 128 0.06 (−0.25, 0.37) 0.699 0.08 (−0.21, 0.36) 0.587
TLR2 132 0 (−0.1, 0.11) 0.935 0 (−0.11, 0.09) 0.823
TNF 132 0.16 (0.02, 0.31) 0.029 0.14 (0.01, 0.27) 0.042
Systolic blood pressure at rest (mmHg)
ALU 134 −0.4 (−0.92, 0.14) 0.146 −0.5 (−1.02, 0.05) 0.074
LINE-1 118 −0.9 (−1.6, −0.14) 0.021 −0.9 (−1.59, −0.12) 0.023
NOS3 122 −0.1 (−0.36, 0.21) 0.582 0 (−0.31, 0.26) 0.854
EDN1 130 −3.0 (−4.93, −0.99) 0.004 −3.0 (−4.89, −1.02) 0.003
NOS2 130 −0.4 (−0.63, −0.1) 0.007 −0.4 (−0.65, −0.13) 0.004
ICAM1 128 −0.1 (−0.73, 0.52) 0.740 −0.2 (−0.86, 0.4) 0.474
TLR2 132 0.1 (−0.11, 0.32) 0.344 0.11 (−0.11, 0.32) 0.323
TNF 132 0 (−0.31, 0.29) 0.940 0.01 (−0.29, 0.31) 0.957
Diastolic blood pressure at rest (mmHg)
ALU 134 −0.4 (−0.81, 0.08) 0.104 −0.3 (−0.77, 0.1) 0.125
LINE-1 118 −0.6 (−1.19, 0.06) 0.074 −0.5 (−1.11, 0.12) 0.112
NOS3 122 −0.2 (−0.42, 0.05) 0.125 −0.1 (−0.34, 0.12) 0.328
EDN1 130 −2.0 (−3.62, −0.29) 0.022 −1.7 (−3.34, −0.12) 0.035
NOS2 130 −0.3 (−0.51, −0.07) 0.012 −0.3 (−0.5, −0.08) 0.008
ICAM1 128 −0.1 (−0.65, 0.41) 0.654 −0.2 (−0.7, 0.35) 0.506
TLR2 132 0.07 (−0.11, 0.24) 0.465 0.05 (−0.12, 0.22) 0.555
TNF 132 −0.1 (−0.36, 0.14) 0.378 −0.1 (−0.34, 0.15) 0.459
a To estimate the effects of DNA methylation on cardiovascular outcomes, the level of each sequence methylation
was examined in relation to cardiovascular outcomes. This association was verified on all the measures performed
in the study, regardless of whether they were measured on samples taken at baseline (i.e., T0) or after physical
training (T1). In the models, the two samples collected at different times are exchangeable, thus assuming that DNA
methylation levels produced similar modifications at the two time points.
4. Discussion
In the present study, we evaluated the effects of a continuative aerobic physical training on
pressure parameters and on methylation levels of ALU and LINE-1 repetitive elements and of six
specific genes (NOS3, EDN1, NOS2, ICAM1, TLR2, TNF) measured on leukocyte DNA.
The cardiovascular efficacy of the exercise-training period is demonstrated by the increase of
VO2peak and the lowering of both DBP and SBP. Our data confirm literature data regarding the protective
role of physical activity on cardiovascular risk factors, such as lower levels of LDL cholesterol and
blood markers of inflammation, reduced blood pressure, decreased insulin resistance and reduction of
body mass index [36–39].
Our results showed that a continuative aerobic physical training is able to modify DNA methylation
in leukocytes. This finding is suggestive of a more generalized effect of physical training, as several
studies showed that DNA methylation levels measured in blood closely correlates with methylation
patterns of other tissues and therefore provides a proxy for methylation patterns in other tissues [6,40,41].
DNA methylation levels showed also associations with blood pressure values. These findings,
taken together, are suggestive of a possible role exerted by DNA methylation in the complex molecular
mechanism that links physical training to changes in cardiovascular performances.
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Accumulating evidence suggests that regular aerobic physical activity could reduce the risk and
incidence of cardiovascular ischemic events in the general population [42]. In particular, physical activity
may be able to confer cardiovascular protection through a direct effect on vessel walls. Physical activity
has been associated with reduced risks of all-cause mortality [43,44] and it has an important role in
preventing cardiovascular diseases [45–47], modulating oxidative stress and inflammation [48].
The relationship between epigenetic modifications and cardiovascular disease is well
consolidated [49–51]. In addition, recent studies suggested that physical exercise is able to alter
epigenetic modifications involved in cardiovascular risk [42,52].
We found a negative association between LINE-1 methylation and systolic pressure and a negative
association between both systolic and diastolic pressure and EDN1 and NOS2 methylation.
The results obtained regarding repetitive element methylation are consistent with previous studies
showing a negative association between cardiovascular diseases and LINE-1 methylation [32,53–56].
In particular, leukocyte hypomethylation of repetitive sequences, such as LINE-1, have been associated
with prevalent ischemic heart disease and stroke in the Normative Aging Study conducted in the
Boston area [32]. In addition, LINE-1 hypomethylation has previously been associated with altered
levels of LDL and HDL [57].
Interestingly, a negative association was also reported between global DNA methylation levels
and the severity of EH [40].
Endothelin- 1 (encoded by EDN1 gene) is a potent arterial vasoconstrictor and an elevated plasma
level is a prognostic marker in patients with cardiovascular diseases as well as a predictor of mortality
in patients with cardiovascular diseases [58]. Therefore, reduction of EDN1 methylation levels may be
involved in mediating the effects of both systolic and diastolic pressure increase.
In mammals, the production of NO is catalyzed by three isoforms of NOS encoded by separate
genes mapped on three different chromosomes: neuronal NOS (NOS1), inducible NOS (NOS2) and
endothelial NOS (NOS3).
Immune activation mediated by pro-inflammatory cytokines is associated with the expression of
NOS2 and the production of NO [59]. Specific studies on NOS2 gene have shown that lower DNA
methylation in the NOS2 promoter is associated with increased NOS2 expression [60]. While NOS3
is constitutively expressed and responsible for the majority of NO produced by the vascular
endothelium, NOS2 expression, and its activity are increased in the presence of reactive oxygen
species (ROS) [61]. We previously reported that DBP was positively associated with NOS2 methylation
levels in Peripheral blood mononuclear cells (PBMCs) in the elderly population of the Normative Aging
Study (NAS) [62]. However, several confounders may be considered, such as the age of the subjects,
diet, previous cardiovascular events. These factors might explain the different results obtained in
different populations, such as the one described in this paper and the NAS population, supporting the
complex effects of epigenetic modifications.
Epigenetics provides a newer vantage point for understanding transcriptional control paradigms in
NO synthases. In particular, these pathways may represent the molecular substrate for the modulation
of cardiovascular disease susceptibility.
The present study must be interpreted taking into account both strengths and limitations. First,
the sample size is limited. Therefore, the results of this study should be considered as preliminary
and we recommend future studies to confirm our findings. However, all study participants were
recruited in the same hospital and clinical investigations were standardized as they were performed by
cardiologists after a training program and using the same instrumentation.
Second, we selected LINE-1, ALU, NOS3, EDN1, NOS2, ICAM1, TLR2, TNF for DNA methylation
analysis for their role in inflammatory pathways and cardiovascular disease and because they are
expressed in many human tissues, including blood, the source of DNA for our study. However,
several other genes might have been included in our study. Future studies investigating a larger
number of target genes, possibly in an unbiased way, should be conducted.
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Third, the quite large variation in the difference between methylation at baseline and after training
suggests that not only physical activity but also other factors might have a role, such as unchangeable
or non-depending individual factors (such as environmental and genetic factors).
Moreover, the study population was characterized by a wide range of blood pressure measures,
giving us the possibility to evaluate the association of DNA methylation and blood pressure in subjects
characterized by variable levels of disease.
Finally, blood DNA is derived from a mixed cell population and we cannot exclude that differences
in the number of subpopulations might have contributed to determine the results we observed in the
present work.
Taken as a whole these factors might contribute to the variability in DNA methylation response
and define individual phenotypes.
5. Conclusions
Our findings provide a rationale to support a role for DNA methylation in mediating the protective
effect of physical training on cardiovascular risk. If these results shall be confirmed, individual measures
of DNA methylation might be useful to assess the beneficial effect of physical activity and to predict
the reduction of cardiovascular risk.
Supplementary Materials: The following are available online at http://www.mdpi.com/1660-4601/16/14/2530/s1,
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